PATENT CLAIM ANALYSIS

Application Number: 16094914
Application Type: Utility
Filing Date: 2018-10
Publication Date: 2019-03
Patent Classification: ["514", "456000"]

Abstract:
The present invention primarily relates to the use of Homoeriodictyol (HED) or a salt thereof or a mixture of HED and one or more salts thereof or a mixture of several salts thereof for reducing the gastric acid secretion-stimulating effect of N-Acetyl-4-aminophenol (Paracetamol).

Claim (Index 16):
The pharmaceutical preparation of  claim 11 , wherein the concentration of paracetamol in the preparation is from 0.001 to 1000 mM.

Metadata:
- Claim Count in Document: 2.0
- Percentile: 97.0
- Lexical Diversity: 1.5
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['14761474', '13018906', '12634756', '10141426', '12046978']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7705597669489506
- 35 USC 102 Novelty (BERT): 0.4919328226163373
- Combined Prediction Score: 0.7426970725156893
- Mean Citation Score: 206.511772
- Max Citation Score: 211.14903
- Similarity Product: 151.6097219810772

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test